15 Participants Needed

TMS for Bipolar Mood Disorders

AW
BA
Overseen ByBlake Andreou, BA
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Massachusetts General Hospital
Must be taking: Psychiatric medications
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This trial is testing if using magnetic fields to stimulate brain cells can help people with bipolar disorder manage their emotions better. Current treatments often don't work well for these patients, so this new approach aims to improve their emotional control by targeting specific brain areas.

Research Team

KK

Kristen K Ellard, PhD

Principal Investigator

Massachusetts General Hospital

Eligibility Criteria

This trial is for adults aged 18-50 with bipolar I disorder who are not in a current mood episode and have been on stable psychiatric medication for at least one month. Participants should not have metal implants sensitive to magnets near their head or neck, no history of seizures, neurosurgery, ECT or TMS treatment within three months, and no active substance use disorders.

Inclusion Criteria

Without major psychiatric illness
No first-degree relative with psychosis
I haven't had ECT or TMS treatments in the last 3 months.
See 13 more

Exclusion Criteria

History of major psychiatric illness, including psychosis
I have had seizures in the past.
I am currently taking medication for my mental health.
See 14 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive transcranial magnetic stimulation (TMS) to improve emotion regulation

15 minutes per session
Multiple sessions (exact number not specified)

Follow-up

Participants are monitored for changes in emotion regulation tasks post-TMS

15 minutes post-TMS

Treatment Details

Interventions

  • TMS
Trial Overview The study tests whether transcranial magnetic stimulation (TMS), a non-invasive brain stimulation technique, can improve emotion regulation in individuals with bipolar disorder. It aims to understand the potential benefits of TMS as an adjunct therapy for mood stabilization.
Participant Groups
2Treatment groups
Active Control
Group I: PatientsActive Control1 Intervention
Individuals with Bipolar 1 Disorder
Group II: ControlsActive Control1 Intervention
Healthy controls

TMS is already approved in United States, European Union, Canada for the following indications:

πŸ‡ΊπŸ‡Έ
Approved in United States as Transcranial Magnetic Stimulation for:
  • Depression
  • Anxiety disorders
  • Post-traumatic stress disorder (PTSD)
  • Obsessive-compulsive disorder (OCD)
πŸ‡ͺπŸ‡Ί
Approved in European Union as Transcranial Magnetic Stimulation for:
  • Depression
  • Anxiety disorders
  • Post-traumatic stress disorder (PTSD)
  • Obsessive-compulsive disorder (OCD)
πŸ‡¨πŸ‡¦
Approved in Canada as Transcranial Magnetic Stimulation for:
  • Depression
  • Anxiety disorders
  • Post-traumatic stress disorder (PTSD)
  • Obsessive-compulsive disorder (OCD)

Find a Clinic Near You

Who Is Running the Clinical Trial?

Massachusetts General Hospital

Lead Sponsor

Trials
3,066
Recruited
13,430,000+

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator

Trials
1,403
Recruited
655,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceΒ·Privacy PolicyΒ·CookiesΒ·Security